| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 217.775 | 84 |
| GSM780708 | Untreated after 4 days (C2_1) | 167.935 | 82 |
| GSM780709 | Untreated after 4 days (C3_1) | 169.279 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 218.142 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 175.825 | 82 |
| GSM780721 | Untreated after 4 days (C3_2) | 166.066 | 82 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 140.343 | 80 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 190.666 | 83 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 157.519 | 81 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 139.264 | 80 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 192.769 | 83 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 205.929 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 198.516 | 83 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 165.271 | 82 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 214.215 | 84 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 212.73 | 84 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 170.437 | 82 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 209.167 | 84 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 259.809 | 86 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 229.653 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 188.341 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 229.047 | 85 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 181.037 | 83 |